AdayAWMatsushitaK.Epidemiology of peripheral artery disease and polyvascular disease. Circ Res2021; 128: 1818–1832.
2.
GornikHLAronowHDGoodneyPP, et al. 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS guideline for the management of lower extremity peripheral artery disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation2024; 149: e1313–e1410.
3.
SaxonJTSafleyDMMena-HurtadoC, et al. Adherence to guideline-recommended therapy—including supervised exercise therapy referral—across peripheral artery disease specialty clinics: Insights from the International PORTRAIT Registry. J Am Heart Assoc2020; 9: e012541.
4.
MinnickCStaffordJStutsrimA, et al. Prescriber implementation of guideline-directed medical therapy remains poor in the peripheral artery disease population. J Vasc Surg. Published online Feb 19, 2025. DOI: 10.1016/j.jvs.2025.02.011.
5.
HibbardJHStockardJMahoneyERTuslerM.Development of the patient activation measure (PAM): Conceptualizing and measuring activation in patients and consumers. Health Serv Res2004; 39: 1005–1026.
6.
HibbardJHMahoneyERStockRTuslerM.Do increases in patient activation result in improved self-management behaviors?Health Serv Res2007; 42: 1443–1463.
7.
AlabiOSanchetiMGrantC, et al. Disease-specific knowledge among veterans with peripheral artery disease. Vasc Med2025; 30: 309–311.
8.
ReillyMAAlagnaMEIrozC, et al. Patient factors associated with activation level in peripheral artery disease. Vasc Med. 2025; 30: 283–292.
9.
LinM-YWengW-SApriliyasariRW, et al. Effects of patient activation intervention on chronic diseases: A meta-analysis. J Nurs Res2020; 28: e116.
10.
CuevasHHeitkemperEHuangYC, et al. A systematic review and meta-analysis of patient activation in people living with chronic conditions. Patient Educ Couns2021; 104: 2200–2212.
